Correction: Factor XIa inhibition as a therapeutic strategy for atherothrombosis.
Publication
, Journal Article
Bailey, E; Lopes, RD; Gibson, CM; Eikelboom, JW; Rao, SV
Published in: J Thromb Thrombolysis
February 2025
Duke Scholars
Published In
J Thromb Thrombolysis
DOI
EISSN
1573-742X
Publication Date
February 2025
Volume
58
Issue
2
Start / End Page
353
Location
Netherlands
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Bailey, E., Lopes, R. D., Gibson, C. M., Eikelboom, J. W., & Rao, S. V. (2025). Correction: Factor XIa inhibition as a therapeutic strategy for atherothrombosis. J Thromb Thrombolysis, 58(2), 353. https://doi.org/10.1007/s11239-024-03064-0
Bailey, Eric, Renato D. Lopes, C Michael Gibson, John W. Eikelboom, and Sunil V. Rao. “Correction: Factor XIa inhibition as a therapeutic strategy for atherothrombosis.” J Thromb Thrombolysis 58, no. 2 (February 2025): 353. https://doi.org/10.1007/s11239-024-03064-0.
Bailey E, Lopes RD, Gibson CM, Eikelboom JW, Rao SV. Correction: Factor XIa inhibition as a therapeutic strategy for atherothrombosis. J Thromb Thrombolysis. 2025 Feb;58(2):353.
Bailey, Eric, et al. “Correction: Factor XIa inhibition as a therapeutic strategy for atherothrombosis.” J Thromb Thrombolysis, vol. 58, no. 2, Feb. 2025, p. 353. Pubmed, doi:10.1007/s11239-024-03064-0.
Bailey E, Lopes RD, Gibson CM, Eikelboom JW, Rao SV. Correction: Factor XIa inhibition as a therapeutic strategy for atherothrombosis. J Thromb Thrombolysis. 2025 Feb;58(2):353.
Published In
J Thromb Thrombolysis
DOI
EISSN
1573-742X
Publication Date
February 2025
Volume
58
Issue
2
Start / End Page
353
Location
Netherlands
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences